A61P 13 - Drugs for disorders of the urinary system

Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
08/2002
08/15/2002	WO2002062321A2 Method for producing a floating tablet containing an active principle
08/15/2002	WO2002062301A2 Method and composition for rejuvinating cells, tissues, organs, hair and nails
08/15/2002	WO2002047685A3 Nmda receptor agonist pharmaceutical compositions
08/15/2002	WO2002034753A3 Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
08/15/2002	WO2002032419A3 Methods for modulating bladder function
08/15/2002	WO2002030860A3 Ketone compounds and compositions for cholesterol management and related uses
08/15/2002	WO2002028434A3 Use of a ppar delta activator for treating inflammatory conditions
08/15/2002	WO2002028433A3 Use of a ppar delta activator in the treatment of diseases related to no inhibit ion or tnf inhibition
08/15/2002	WO2002026729A3 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders
08/15/2002	WO2002022212A8 Combination therapy for treatment of autoimmune diseases using b cell depleting/immunoregulatory antibody combination
08/15/2002	WO2002016381B1 Composition and method for inhibiting platelet aggregation
08/15/2002	WO2001066572A9 Polynucleotides isolated from e. coli of nature b2/d+ a-, and uses thereof
08/15/2002	US20020111505 Purified 15-epi-lipoxin compound has a longer tissue half-life; anticancer agents
08/15/2002	US20020111493 Amidino compounds useful as nitric oxide synthase inhibitors
08/15/2002	US20020111481 Generating preferential oligosaccharides derivatives; obtain lactoside, incubate with benzaldehyde dimethylacetal, recover product
08/15/2002	US20020111366 Therapy for brain disorders; strokes
08/15/2002	US20020111355 Antitumor agents; contraceptives
08/15/2002	US20020111353 Antiinflammatory agents; central nervous system disorders;antidiabgetic agents; rheumatic disorders
08/15/2002	US20020111333 Hypotensive agents; cardiovascular disorders
08/15/2002	US20020111315 Synergistic mixture with antilipemic agent
08/15/2002	US20020110804 Secreted factors
08/15/2002	CA2437630A1 Method for producing a floating tablet containing an active principle
08/15/2002	CA2437571A1 Receptors and membrane-associated proteins
08/15/2002	CA2437405A1 Potassium channel openers
08/15/2002	CA2437400A1 Aminal diones as potassium channel openers
08/15/2002	CA2437260A1 Oxazolyl-pyrazole derivatives as kinase inhibitors
08/15/2002	CA2437248A1 Jnk inhibitor
08/15/2002	CA2437085A1 Pharmaceutical formulation comprising pyrazolo[4,3-d]pyrimidines and endothelin receptor antagonists or thienopyrimidines and endothelin receptor antagonists
08/15/2002	CA2436741A1 Aryl substituted alkylcarboxylic acids as hypocholesterolemic agents
08/15/2002	CA2436738A1 Salts of pyrimidine derivatives for use against coronary heart disease and atherosclerose
08/15/2002	CA2435989A1 Pharmaceutical composition for the therapy of lower urinary tract symptoms
08/15/2002	CA2435844A1 Method and composition for rejuvinating cells, tissues, organs, hair and nails
08/14/2002	EP1231211A1 Thiazolidinedione derivatives as antidiabetic agents
08/14/2002	EP1230929A1 Inhibitors of cell regulatory factors and methods for preventing or reducing scarring
08/14/2002	EP1230369A2 Polypeptide hormone phosphatonin
08/14/2002	EP1230367A1 19 human secreted proteins
08/14/2002	EP1230360A2 15 human secreted proteins
08/14/2002	EP1230342A1 Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues
08/14/2002	EP1230244A2 Pyrazolecarboxylic acid tricyclic derivatives, preparation and pharmaceutical compositions containing same
08/14/2002	EP1230243A1 Poycyloalkylpurines as adenosine receptor antagonists
08/14/2002	EP1230241A2 Adenosine receptor antagonists and methods of making and using the same
08/14/2002	EP1230236A1 Compound with growth hormone releasing properties
08/14/2002	EP1230210A1 Aminoalcohol derivatives useful for the treatment of gastrointestinal disorders
08/14/2002	EP1230209A2 Stable salts of novel derivatives of 3,3-diphenylpropylamines
08/14/2002	EP0807111B1 Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same
08/14/2002	DE10106214A1 Neue Alkyl-phenylimino-imidazolidin-Derivate zur Behandlung der Harninkontinenz New alkyl-phenylimino-imidazolidine derivatives for treating urinary incontinence
08/14/2002	CN1364085A Use of phyllanthus for treating chronically inflammatory and fibrotic processes
08/14/2002	CN1363375A Medicinal composition for relaxing chronic renal failure
08/14/2002	CN1363348A Nano medicine 'Pulean' and its preparing process
08/14/2002	CN1363343A Nano medicine 'Bazheng' and its preparing process
08/14/2002	CN1363314A Medicine for treating renal calculus and its preparing process
08/14/2002	CN1363308A Nano medicine 'Jisheng Shenqi' and its preparing process
08/13/2002	US6433182 Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses
08/13/2002	US6433171 Dipeptide derivatives
08/13/2002	US6433140 Stable bactericidal permeability-increasing protein products and pharmaceutical compositions containing the same
08/13/2002	US6432996 Pharmaceutical composition
08/13/2002	US6432994 Cardiovascular disorders, glaucoma; antiinflammatory, wound healing, hypotensive, antiasthmatic, and antianaphylactic agents
08/13/2002	US6432983 Treating estrogen-dependent cancer, endometriosis, osteoporosis, post-menopausal disorders and hyperlipidemia; restenosis inhibitors
08/13/2002	US6432978 4-hydroxy-1-methyl-1,2-dihydroquinolin-2-one derivatives; cardiovascular, atopic, and rheumatic disorders; antiallergens, antiinflammatory agents, antiasthmatics, and hypotensive agents
08/13/2002	US6432947 N-heterocyclic derivatives as NOS inhibitors
08/13/2002	US6432945 Dipeptide derivatives
08/13/2002	US6432940 Uses for androst-5-ene-3β, 17β-diol
08/08/2002	WO2002061110A2 Nucleic acid derivatives
08/08/2002	WO2002061095A1 Novel protein and dna thereof
08/08/2002	WO2002060929A2 Polymer conjugates of neublastin and methods of using same
08/08/2002	WO2002060903A1 Substituted indolines as 5-ht receptor ligands
08/08/2002	WO2002060900A2 Antagonists of mcp-1 function and methods of use thereof
08/08/2002	WO2002060898A1 Thiazolyl-, oxazolyl-, pyrrolyl-, and imidazolyl-acid amide derivatives useful as inhibitors of pde4 isozymes
08/08/2002	WO2002060897A2 Process for making substituted 8-arylquinolinium benzenesulfonate
08/08/2002	WO2002060896A1 Ether derivatives useful as inhibitors of pde4 isozymes
08/08/2002	WO2002060895A1 Diazocine derivatives and their use as tryptase inhibitors
08/08/2002	WO2002060875A1 Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes
08/08/2002	WO2002060859A2 Cyclic derivatives as modulators of chemokine receptor activity
08/08/2002	WO2002060858A1 Novel compound having maillard reaction inhibitory activity
08/08/2002	WO2002060534A2 Selective alpha 1 antagonists a + d
08/08/2002	WO2002060489A1 Method of using a variant of vegf receptor to treat psoriasis and to enhance wound healing
08/08/2002	WO2002060467A2 Compositions and methods for improving kidney function
08/08/2002	WO2002060449A2 Pharmaceutical formulation containing pyrazolo[4,3-d]pyrimidine and nitrates or thienopyrimidines and nitrates
08/08/2002	WO2002060445A1 Kappa opioid receptor ligands
08/08/2002	WO2002060421A2 Use of 2-amino-1(4-hydroxy-2-methanesulphonamidophenyl)ethanol for treating urinary incontinence
08/08/2002	WO2002060411A2 Process for production of nanoparticles and microparticles by spray freezing into liquid
08/08/2002	WO2002060378A2 Substituted aryl compounds as cyclooxygenase-2 selective inhibitors, compositions and methods of use
08/08/2002	WO2002044142A3 Piperazine derivatives, their preparation and their use for treating central nervous system (cns) disorders
08/08/2002	WO2002034716A3 Pyrrolidine modulators of ccr5 chemokine receptor activity
08/08/2002	WO2002032900A3 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents
08/08/2002	WO2002019971A9 4-halogenated 17-methylene steroids, method for the production thereof and pharmaceutical compositions containing these compounds
08/08/2002	WO2002014347A3 Method for producing peptide salts, their use, and pharmaceutical preparations containing these peptide salts
08/08/2002	WO2002010140A3 Imidazolyl derivatives
08/08/2002	WO2001096546A3 Protein phosphatases
08/08/2002	WO2001093840A3 Ligands of integrin receptors
08/08/2002	WO2001087935A3 Methods of modulating angiogenesis by regulating the expression of pituitary tumor transforming gene (pttg)
08/08/2002	WO2001081585A3 A thymus expressed human cytochrome p450 (p450tec)
08/08/2002	WO2001081312A3 Method of treatment using phenyl and biaryl derivatives as prostaglandin e inhibitors and compounds useful therefore
08/08/2002	WO2001080890A3 Formulations and methods of using nitric oxide mimetics against a malignant cell phenotype
08/08/2002	WO2001077376A3 Diagnosis of diseases associated with metastasis
08/08/2002	WO2001076451A9 Diagnosis of diseases associated with metabolism
08/08/2002	WO2001032925A9 Modulation of neuroendocrine differentiation by protein 25.1
08/08/2002	WO2001013714A3 Prostatic cell line and animal model of a prostatic tumor
08/08/2002	WO2001009090A3 Hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines
08/08/2002	US20020107363 B7-Like molecules and uses thereof

1 ... 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 ... 562